Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Z R Han

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Cell and Developmental Biology|September 7, 2016
The Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor FamilySean P Kennedy, Jordan F Hastings, Jeremy Z R Han, et al.
Frontiers in Cell and Developmental Biology|October 29, 2020
Histone Deacetylases and Histone Deacetylase Inhibitors in NeuroblastomaMonica Phimmachanh, Jeremy Z R Han, Yolande E I O'Donnell, et al.
Journal of Personalized Medicine|June 2, 2021
Personalized Medicine for Neuroblastoma: Moving from Static Genotypes to Dynamic Simulations of Drug ResponseJeremy Z R Han, Jordan F Hastings, Monica Phimmachanh, et al.
Journal of Visualized Experiments : Jove|July 10, 2018
Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification (BiCAP)Jordan F Hastings, Jeremy Z R Han, Robert F Shearer, et al.
Science Signaling|July 14, 2016
Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimersDavid R Croucher, Mary Iconomou, Jordan F Hastings, et al.
Scientific Reports|November 6, 2020
A zebrafish functional genomics model to investigate the role of human A20 variants in vivoDaniele Cultrone, Nathan W Zammit, Eleanor Self, et al.
Science Advances|November 28, 2025
Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastomaJeremy Z R Han, Monica Phimmachanh, Jordan F Hastings, et al.
Breast Cancer Research : BCR|March 23, 2019
Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancerSean P Kennedy, Jeremy Z R Han, Neil Portman, et al.
Science Advances|March 3, 2023
Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastomaJordan F Hastings, Sharissa L Latham, Alvin Kamili, et al.
Science Translational Medicine|July 27, 2018
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapyKieren D Marini, David R Croucher, Rachael A McCloy, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Cell and Developmental Biology|September 7, 2016
The Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor FamilySean P Kennedy, Jordan F Hastings, Jeremy Z R Han, et al.
Frontiers in Cell and Developmental Biology|October 29, 2020
Histone Deacetylases and Histone Deacetylase Inhibitors in NeuroblastomaMonica Phimmachanh, Jeremy Z R Han, Yolande E I O'Donnell, et al.
Journal of Personalized Medicine|June 2, 2021
Personalized Medicine for Neuroblastoma: Moving from Static Genotypes to Dynamic Simulations of Drug ResponseJeremy Z R Han, Jordan F Hastings, Monica Phimmachanh, et al.
Journal of Visualized Experiments : Jove|July 10, 2018
Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification (BiCAP)Jordan F Hastings, Jeremy Z R Han, Robert F Shearer, et al.
Science Signaling|July 14, 2016
Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimersDavid R Croucher, Mary Iconomou, Jordan F Hastings, et al.
Scientific Reports|November 6, 2020
A zebrafish functional genomics model to investigate the role of human A20 variants in vivoDaniele Cultrone, Nathan W Zammit, Eleanor Self, et al.
Science Advances|November 28, 2025
Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastomaJeremy Z R Han, Monica Phimmachanh, Jordan F Hastings, et al.
Breast Cancer Research : BCR|March 23, 2019
Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancerSean P Kennedy, Jeremy Z R Han, Neil Portman, et al.
Science Advances|March 3, 2023
Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastomaJordan F Hastings, Sharissa L Latham, Alvin Kamili, et al.
Science Translational Medicine|July 27, 2018
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapyKieren D Marini, David R Croucher, Rachael A McCloy, et al.
Pageof 2